Get the app!
Back to Trades

Smith Mark Douglas

DirectorCIK 0001756253

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
4
Buy transactions
0
Sell transactions
1
Companies
3
Active
2025–2026

Smith Mark Douglas, Director, has filed 4 reports across 3 companies, totaling $652.5K in disclosed volume. Sales ($266.7K) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.

Trading History

4 loaded
Jun 26PHR
Phreesia, Inc.
Smith Mark DouglasDirectorGrant$185.0K
Jun 17JAZZ
Jazz Pharmaceuticals plc
Smith Mark DouglasDirectorSell$266.7K
May 21TDOC
Teladoc Health, Inc.
Smith Mark DouglasDirectorOther$0
Aug 11JAZZ
Jazz Pharmaceuticals plc
Smith Mark DouglasDirectorGrant$0

4 filings